Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Nov 17;14:1327256. doi: 10.3389/fphar.2023.1327256

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Xikui Lu 1,2,3, Lu Zhang 1,2, Hangxing Huang 1,2,3, Xiangping Wu 1,2,3, Zhenting Wang 1,2,3, Ling Huang 1,2, Jingyang Li 1,2, Huimin Yu 1,2, Hongyan Zhang 1,4, Jian Xiao 1,2,*
PMCID: PMC10693328  PMID: 38044935

In the published article, there is a missing Funding statement. The correct Funding statement appears below.

“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was supported by Hunan Provincial Natural Science Foundation of 2021 (2021JJ31043); Changsha Natural Science Foundation of 2020 (kq2007039); 2020 National Geriatric Disease Clinical Medicine Research Center Appropriate Technology Promotion Project (XYYYJSTG-15); Parallel and Distributed Processing for the Stable Support Project of the National Defense Science and Technology Key Laboratory (WDZC20205500121); Key Research Project of Ningxia Hui Autonomous Region in 2021 (Major Project) (2021BEG01001); Degree & Postgraduate Education Reform Project of Central South University (2022JGB067)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES